Your browser is no longer supported. Please, upgrade your browser.
STJ St. Jude Medical Inc. monthly Stock Chart
STJ [NYSE]
St. Jude Medical Inc.
IndexS&P 500 P/E30.23 EPS (ttm)2.49 Insider Own2.40% Shs Outstand289.59M Perf Week21.65%
Market Cap21.82B Forward P/E17.08 EPS next Y4.41 Insider Trans-0.57% Shs Float276.96M Perf Month37.29%
Income713.00M PEG2.85 EPS next Q1.06 Inst Own86.70% Short Float1.73% Perf Quarter44.09%
Sales5.64B P/S3.87 EPS this Y-11.10% Inst Trans-0.05% Short Ratio1.57 Perf Half Y17.77%
Book/sh14.31 P/B5.27 EPS next Y8.59% ROA6.20% Target Price68.83 Perf Year7.66%
Cash/sh1.12 P/C67.15 EPS next 5Y10.61% ROE17.80% 52W Range48.55 - 79.64 Perf YTD22.70%
Dividend1.24 P/FCF- EPS past 5Y2.30% ROI9.30% 52W High-5.38% Beta1.30
Dividend %1.65% Quick Ratio1.10 Sales past 5Y1.40% Gross Margin67.50% 52W Low55.22% ATR1.90
Employees18000 Current Ratio1.70 Sales Q/Q7.70% Oper. Margin16.50% RSI (14)81.39 Volatility1.61% 1.69%
OptionableYes Debt/Eq1.48 EPS Q/Q-63.70% Profit Margin12.60% Rel Volume2.39 Prev Close75.85
ShortableYes LT Debt/Eq1.36 EarningsApr 20 BMO Payout46.70% Avg Volume3.06M Price75.36
Recom2.60 SMA2021.17% SMA5030.74% SMA20022.30% Volume7,304,350 Change-0.65%
May-03-16Downgrade Credit Suisse Outperform → Neutral
May-02-16Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-29-16Downgrade Needham Buy → Hold
Apr-28-16Downgrade Piper Jaffray Overweight → Neutral
Mar-17-16Initiated Nomura Buy
Feb-08-16Upgrade Canaccord Genuity Sell → Hold $54
Jan-28-16Reiterated Oppenheimer Perform $72 → $64
Jan-25-16Reiterated RBC Capital Mkts Sector Perform $66 → $57
Jan-19-16Downgrade Wells Fargo Outperform → Market Perform
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy
Oct-22-15Reiterated RBC Capital Mkts Sector Perform $75 → $66
Oct-22-15Downgrade Stifel Buy → Hold
Jul-23-15Reiterated Stifel Buy $81 → $89
Jul-23-15Reiterated RBC Capital Mkts Sector Perform $71 → $75
Jul-23-15Reiterated Barclays Overweight $84 → $86
Jul-23-15Downgrade Deutsche Bank Buy → Hold $76 → $77
Jul-21-15Reiterated Needham Strong Buy $86 → $91
Jul-08-15Upgrade Wells Fargo Market Perform → Outperform
Apr-23-15Upgrade Credit Suisse Neutral → Outperform $74 → $84
Apr-23-15Reiterated Stifel Buy $73 → $81
May-04-16 04:42PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:41PM  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of St. Jude Medical, Inc. Buyout Business Wire
01:32PM  INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of St. Jude Medical, Inc. and Encourages Shareholders to Contact the Firm for Additional Information Business Wire
12:32PM  ST. JUDE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of St. Jude Medical Inc. (STJ) Over the Proposed Sale of the Company to Abbott Business Wire
09:15AM  St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2016 Business Wire
06:45AM  Abbott Buys St. Jude Medical for $85 per Share in Cash and Stock Market Realist
May-03-16 04:14PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of St. Jude Medical Inc. for Cash & Stock to Abbott is Fair to Shareholders Business Wire
10:57AM  St. Jude Medical, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Abbott Laboratories Business Wire
06:28AM  St. Jude Medical downgraded by Credit Suisse Briefing.com
May-02-16 01:59PM  ST. JUDE MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of St. Jude Medical, Inc. PR Newswire
01:29PM  IHIs Large-Caps: Abbott to Acquire St. Jude Medical Market Realist
12:39PM  SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of St. Jude Medical, Inc. and Encourages Investors to Contact the Firm for Additional Information Business Wire
11:30AM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of St. Jude Medical Inc. for Cash & Stock to Abbott is Fair to Shareholders PR Newswire
06:02AM  Banker Fees Resuscitated By Healthcare M&A at The Wall Street Journal
Apr-29-16 05:22PM  Worst may be over for embattled pharma Yahoo Finance Contributors
02:14PM  Analysts Split On Abbott Lab's Purchase Of St. Jude at Barrons.com
11:12AM  Correction: Abbott-St Jude Acquisition story AP
10:34AM  Ryan & Maniskas, LLP Announces Investigation of St. Jude Medical Inc. PR Newswire
09:42AM  Faber Report: Abbott Labs CEO says Alere 'working through... CNBC
09:20AM  Abbott to Buy St. Jude Medical for $25 Billion at Investopedia
Apr-28-16 05:56PM  Why Textura, St. Jude Medical, and Cliffs Natural Resources Jumped Today at Motley Fool +25.57%
04:44PM  St. Jude Medical, Inc. -- Moody's reviews St. Jude Medical's Baa2 rating for downgrade at Moody's
04:43PM  US STOCKS-Wall St sinks on BOJ fears, Icahn comments Reuters
03:42PM  Robbins Arroyo LLP: Acquisition of St. Jude Medical, Inc. (STJ) by Abbott Laboratories (ABT) May Not Be in Shareholders' Best Interests Business Wire
03:41PM  US STOCKS-Wall St flounders on BOJ fears as Facebook, M&A boosts wane Reuters
03:20PM  Abbott Labs buying St. Jude Medical in $25B deal at American City Business Journals
03:01PM  Takeover Thursday CNBC
02:33PM  Amazon earnings on the way Yahoo Finance
02:06PM  Morningstar Analyst: Abbott Laboratories' Acquisition Of St. Jude Medical 'Makes A Lot Of Strategic Sense' Benzinga
02:00PM  Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients Business Wire
01:38PM  $31 Billion St. Jude Purchase Will Take a While for Abbott to Digest at TheStreet
01:05PM  LPC: Abbott's US$17.2bn loan backing St. Jude acq. set to boost M&A volume Reuters
01:01PM  Big health care deals CNBC
12:36PM  Thursday links: costs vs. discipline Yahoo Finance Contributors
12:00PM  Why St. Jude Medical, Inc. Acquired a Higher Price Today at Motley Fool
11:34AM  ST. JUDE MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
11:06AM  Abbott Boosts Cardio Device Business With $25 Billion St. Jude Buy at Investor's Business Daily
10:39AM  Abbott 'bulks up' with St. Jude CNBC
10:20AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of St. Jude Medical Inc. for Cash & Stock to Abbott is Fair to Shareholders Accesswire
10:10AM  Abbott-St. Jude Combination: Why It Makes Sense Bloomberg
10:05AM  Heres Why Traders Are Buzzing About These Five Hot Stocks at Insider Monkey
09:49AM  'Just right' timing to buy St. Jude: Abbott CEO CNBC
09:47AM  Product makes us competitive, not tax: Abbott CEO CNBC
09:45AM  Abbott Labs' 'super transaction' after buying St. Jude CNBC
09:40AM  Stocks to Watch: Facebook, Abbott Labs, St. Jude at The Wall Street Journal
09:27AM  Lot of room for growth in M&A market? Fox Business Video
09:24AM  Facebook surges to new high, Priceline CEO steps down Yahoo Finance
09:01AM  Abbott Labs to buy St. Jude Medical CNBC
08:30AM  St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of St. Jude Medical, Inc.; Are Shareholders Getting a Fair Price? PR Newswire
08:10AM  GDP disappoints, BOJ surprise Yahoo Finance
08:09AM  Abbott to spend $19.3 billion to buy device maker St. Jude Medical at Los Angeles Times
07:54AM  Abbott to Purchase St. Jude Medical in $25 Billion Deal Bloomberg
07:38AM  St. Jude Soars 30% After Abbott Announces $25 Billion Acquisition Benzinga
07:21AM  ST JUDE MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal EDGAR Online
07:18AM  Abbott Labs to buy St. Jude CNBC
07:00AM  Abbott Labs is buying St. Jude Medical for $25 billion Business Insider
06:56AM  Abbott to acquire St. Jude Medical for $25 bln Reuters
06:55AM  Abbott to buy St. Jude for $85 per share CNBC
06:53AM  Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion at Bloomberg
Apr-24-16 10:06AM  St. Jude Medicals Valuation Compared to Peers Market Realist
Apr-22-16 06:05PM  Can Innovation Drive St. Jude Medicals Growth? Market Realist
04:27PM  ETFs with exposure to St. Jude Medical, Inc. : April 22, 2016 at Capital Cube
Apr-21-16 11:44AM  St. Jude Medical, Inc. :STJ-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
11:06AM  Thoratec Acquisition: The Impact on St. Judes Growth Potential Market Realist
08:58AM  St. Jude Medical (STJ) Stock Price Target Raised at Barclays at TheStreet
Apr-19-16 11:09AM  St. Jude Medical (STJ) Stock Lower Ahead of Earnings at TheStreet
09:42AM  How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? at Motley Fool
08:00AM  St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark Business Wire
Apr-18-16 03:55PM  St. Jude Medicals Market Position and Opportunities
03:54PM  St. Jude Medical: Stock Performance Compared to Peers
03:44PM  Large-Cap Stock Update: St. Jude Gains 6% on Implant News
08:19AM  St. Jude Medical (STJ) Q1 Earnings: What's in the Cards?
08:00AM  St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology Business Wire
Apr-15-16 05:04AM  What Are Analysts Recommendations for Medtronic?
Apr-14-16 12:37PM  St. Jude Medical is Turning the Corner (STJ) at Investopedia
09:55AM  Discussing Edwards Lifesciences Latest Valuation
Apr-13-16 06:25PM  How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? at Motley Fool
Apr-11-16 03:14PM  Large-Cap News: Edwards Surged on SAPIENT 3 TAVR Data
08:00AM  St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy Business Wire
Apr-09-16 09:40AM  3 Charts Show Why Abiomed Could Get Bought at Motley Fool
Apr-08-16 09:00AM  Kessler Topaz Meltzer & Check, LLP and Motley Rice LLC Announce Pendency of Class Action on Behalf of Purchasers of St. Jude Medical, Inc. Common Stock PR Newswire
Apr-07-16 08:00AM  St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement Business Wire
Apr-05-16 04:15PM  St. Jude Medical Announces First Quarter 2016 Earnings Conference Call Business Wire
09:43AM  The Worst Mistakes Abiomed, Inc. Investors Can Make Right Now at Motley Fool
Apr-04-16 08:00AM  St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations Business Wire
Apr-03-16 09:40AM  New Independent Data Confirms Benefits of the St. Jude Medical CardioMEMS HF System Business Wire
Apr-01-16 11:24AM  Earnings Weakness Is Showing Up in an Unexpected Place: Healthcare at The Wall Street Journal
Mar-30-16 12:07PM  Read This Before You Sell Abiomed, Inc. Stock at Motley Fool
Mar-29-16 08:07AM  St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads at noodls
08:00AM  St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads Business Wire
Mar-18-16 08:16AM  St. Jude Medical, Inc. breached its 50 day moving average in a Bearish Manner : STJ-US : March 18, 2016
Mar-11-16 01:30PM  St. Jude (STJ): Nanotism Pacemaker's MRI Feature CE Marked
Mar-10-16 04:15PM  Pay dropped dramatically in Dan Starks' last year as St. Jude CEO at bizjournals.com
08:00AM  St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker Business Wire
Mar-07-16 08:08AM  St. Jude Medical, Inc. breached its 50 day moving average in a Bullish Manner : STJ-US : March 7, 2016
Mar-02-16 04:05PM  St. Jude Medical to Present at the Barclays Global Healthcare Conference Business Wire
09:35AM  Michael Castors Sio Capital Managements New Bets For This Quarter at Insider Monkey
Mar-01-16 12:11PM  Medtronic Sales, Operating Margin Mar Otherwise Solid Quarter
Feb-27-16 01:04PM  ST JUDE MEDICAL INC Financials
Feb-23-16 02:52PM  ST JUDE MEDICAL INC Files SEC form 10-K, Annual Report
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients with tachycardia. It also provides atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems; and pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, heart failure monitoring devices, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including heart valve replacement and repair products, and structural heart defect devices; neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders; and thoratec products comprising ventricular assist devices and percutaneous heart pumps. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fecho JeffVP, Global QualityJan 27Option Exercise35.277,075249,5358,912Jan 29 04:51 PM
DEVENUTI RICHARD RDirectorMay 02Option Exercise40.938,800360,18439,630May 04 04:03 PM
ESSIG STUARTDirectorApr 22Option Exercise40.938,800360,18445,099Apr 26 04:25 PM
Fecho JeffVP, Global QualityFeb 05Option Exercise35.1710,408366,05712,816Feb 09 04:17 PM
Fecho JeffVP, Global QualityFeb 05Sale51.7110,408538,1985,741Feb 09 04:17 PM
HILL BARBARA BDirectorFeb 03Option Exercise40.938,800360,18429,185Feb 05 04:24 PM
WIDENSOHLER STEFAN KDirectorFeb 01Option Exercise40.938,800360,18431,288Feb 03 04:35 PM
Zurbay DonaldVP Finance and CFODec 21Sale60.963,106189,34219,284Dec 22 04:00 PM
HEINMILLER JOHN CExecutive Vice PresidentDec 18Sale61.168,009489,830237,211Dec 22 04:01 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Option Exercise41.652,999124,9083,354Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Option Exercise34.9613,333466,12223,388Nov 04 05:03 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Sale64.354,595295,690355Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Sale64.2913,333857,17910,055Nov 04 05:03 PM
Zellers JasonVP, General Counsel & Corp SecOct 31Sale64.6629419,01010,055Nov 04 05:03 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Option Exercise40.55120,0004,866,0006,232,363Oct 30 04:31 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Sale62.36120,0007,483,3916,112,363Oct 30 04:31 PM
Fecho JeffVP, Global QualityOct 26Option Exercise44.6375033,4734,403Oct 28 04:31 PM
Fecho JeffVP, Global QualityOct 26Sale62.9075047,1753,653Oct 28 04:31 PM
STARKS DANIEL JChairman, CEO & PresidentJul 29Option Exercise40.55100,0004,055,0006,212,363Jul 31 04:30 PM
STARKS DANIEL JChairman, CEO & PresidentJul 29Sale73.93100,0007,393,0006,112,363Jul 31 04:30 PM